230 related articles for article (PubMed ID: 20573748)
1. Homozygous mutations in NEUROD1 are responsible for a novel syndrome of permanent neonatal diabetes and neurological abnormalities.
Rubio-Cabezas O; Minton JA; Kantor I; Williams D; Ellard S; Hattersley AT
Diabetes; 2010 Sep; 59(9):2326-31. PubMed ID: 20573748
[TBL] [Abstract][Full Text] [Related]
2. Permanent neonatal diabetes mellitus and neurological abnormalities due to a novel homozygous missense mutation in NEUROD1.
Demirbilek H; Hatipoglu N; Gul U; Tatli ZU; Ellard S; Flanagan SE; De Franco E; Kurtoglu S
Pediatr Diabetes; 2018 Aug; 19(5):898-904. PubMed ID: 29521454
[TBL] [Abstract][Full Text] [Related]
3. Ophthalmological phenotype associated with homozygous null mutation in the NEUROD1 gene.
Orosz O; Czeglédi M; Kántor I; Balogh I; Vajas A; Takács L; Berta A; Losonczy G
Mol Vis; 2015; 21():124-30. PubMed ID: 25684977
[TBL] [Abstract][Full Text] [Related]
4. Beta-cell dysfunction in late-onset diabetic subjects carrying homozygous mutation in transcription factors NeuroD1 and Pax4.
Kanatsuka A; Tokuyama Y; Nozaki O; Matsui K; Egashira T
Metabolism; 2002 Sep; 51(9):1161-5. PubMed ID: 12200761
[TBL] [Abstract][Full Text] [Related]
5. A homozygous missense mutation in NEUROD1 is associated with nonsyndromic autosomal recessive retinitis pigmentosa.
Wang F; Li H; Xu M; Li H; Zhao L; Yang L; Zaneveld JE; Wang K; Li Y; Sui R; Chen R
Invest Ophthalmol Vis Sci; 2014 Dec; 56(1):150-5. PubMed ID: 25477324
[TBL] [Abstract][Full Text] [Related]
6. Wolcott-Rallison syndrome is the most common genetic cause of permanent neonatal diabetes in consanguineous families.
Rubio-Cabezas O; Patch AM; Minton JA; Flanagan SE; Edghill EL; Hussain K; Balafrej A; Deeb A; Buchanan CR; Jefferson IG; Mutair A; ; Hattersley AT; Ellard S
J Clin Endocrinol Metab; 2009 Nov; 94(11):4162-70. PubMed ID: 19837917
[TBL] [Abstract][Full Text] [Related]
7. Permanent Neonatal Diabetes and Enteric Anendocrinosis Associated With Biallelic Mutations in NEUROG3.
Rubio-Cabezas O; Jensen JN; Hodgson MI; Codner E; Ellard S; Serup P; Hattersley AT
Diabetes; 2011 Apr; 60(4):1349-53. PubMed ID: 21378176
[TBL] [Abstract][Full Text] [Related]
8. Maturity onset diabetes of the young in India - a distinctive mutation pattern identified through targeted next-generation sequencing.
Chapla A; Mruthyunjaya MD; Asha HS; Varghese D; Varshney M; Vasan SK; Venkatesan P; Nair V; Mathai S; Paul TV; Thomas N
Clin Endocrinol (Oxf); 2015 Apr; 82(4):533-42. PubMed ID: 25041077
[TBL] [Abstract][Full Text] [Related]
9. NEUROD1 Is Required for the Early α and β Endocrine Differentiation in the Pancreas.
Bohuslavova R; Smolik O; Malfatti J; Berkova Z; Novakova Z; Saudek F; Pavlinkova G
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34201511
[TBL] [Abstract][Full Text] [Related]
10. A family with the Arg103Pro mutation in the NEUROD1 gene detected by next-generation sequencing - Clinical characteristics of mutation carriers.
Szopa M; Ludwig-Galezowska AH; Radkowski P; Skupien J; Machlowska J; Klupa T; Wolkow P; Borowiec M; Mlynarski W; Malecki MT
Eur J Med Genet; 2016 Feb; 59(2):75-9. PubMed ID: 26773576
[TBL] [Abstract][Full Text] [Related]
11. Biallelic PDX1 (insulin promoter factor 1) mutations causing neonatal diabetes without exocrine pancreatic insufficiency.
De Franco E; Shaw-Smith C; Flanagan SE; Edghill EL; Wolf J; Otte V; Ebinger F; Varthakavi P; Vasanthi T; Edvardsson S; Hattersley AT; Ellard S
Diabet Med; 2013 May; 30(5):e197-200. PubMed ID: 23320570
[TBL] [Abstract][Full Text] [Related]
12. Mutations in NEUROD1 are associated with the development of type 2 diabetes mellitus.
Malecki MT; Jhala US; Antonellis A; Fields L; Doria A; Orban T; Saad M; Warram JH; Montminy M; Krolewski AS
Nat Genet; 1999 Nov; 23(3):323-8. PubMed ID: 10545951
[TBL] [Abstract][Full Text] [Related]
13. The first case of NEUROD1-MODY reported in Latin America.
Abreu GM; Tarantino RM; Cabello PH; Zembrzuski VM; da Fonseca ACP; Rodacki M; Zajdenverg L; Campos Junior M
Mol Genet Genomic Med; 2019 Dec; 7(12):e989. PubMed ID: 31578821
[TBL] [Abstract][Full Text] [Related]
14. NEUROD1-deficient diabetes (MODY6): Identification of the first cases in Japanese and the clinical features.
Horikawa Y; Enya M; Mabe H; Fukushima K; Takubo N; Ohashi M; Ikeda F; Hashimoto KI; Watada H; Takeda J
Pediatr Diabetes; 2018 Mar; 19(2):236-242. PubMed ID: 28664602
[TBL] [Abstract][Full Text] [Related]
15. Mutations of maturity-onset diabetes of the young (MODY) genes in Thais with early-onset type 2 diabetes mellitus.
Plengvidhya N; Boonyasrisawat W; Chongjaroen N; Jungtrakoon P; Sriussadaporn S; Vannaseang S; Banchuin N; Yenchitsomanus PT
Clin Endocrinol (Oxf); 2009 Jun; 70(6):847-53. PubMed ID: 18811724
[TBL] [Abstract][Full Text] [Related]
16. Clinical characteristics and molecular genetic analysis of 22 patients with neonatal diabetes from the South-Eastern region of Turkey: predominance of non-KATP channel mutations.
Demirbilek H; Arya VB; Ozbek MN; Houghton JA; Baran RT; Akar M; Tekes S; Tuzun H; Mackay DJ; Flanagan SE; Hattersley AT; Ellard S; Hussain K
Eur J Endocrinol; 2015 Jun; 172(6):697-705. PubMed ID: 25755231
[TBL] [Abstract][Full Text] [Related]
17. Four novel cases of permanent neonatal diabetes mellitus caused by homozygous mutations in the glucokinase gene.
Bennett K; James C; Mutair A; Al-Shaikh H; Sinani A; Hussain K
Pediatr Diabetes; 2011 May; 12(3 Pt 1):192-6. PubMed ID: 21518409
[TBL] [Abstract][Full Text] [Related]
18. Microcephaly, epilepsy, and neonatal diabetes due to compound heterozygous mutations in IER3IP1: insights into the natural history of a rare disorder.
Shalev SA; Tenenbaum-Rakover Y; Horovitz Y; Paz VP; Ye H; Carmody D; Highland HM; Boerwinkle E; Hanis CL; Muzny DM; Gibbs RA; Bell GI; Philipson LH; Greeley SA
Pediatr Diabetes; 2014 May; 15(3):252-6. PubMed ID: 24138066
[TBL] [Abstract][Full Text] [Related]
19. Clinical Characteristics and Long-term Follow-up of Patients with Diabetes Due To PTF1A Enhancer Mutations.
Demirbilek H; Cayir A; Flanagan SE; Yıldırım R; Kor Y; Gurbuz F; Haliloğlu B; Yıldız M; Baran RT; Akbas ED; Demiral M; Ünal E; Arslan G; Vuralli D; Buyukyilmaz G; Al-Khawaga S; Saeed A; Al Maadheed M; Khalifa A; Onal H; Yuksel B; Ozbek MN; Bereket A; Hattersley AT; Hussain K; De Franco E
J Clin Endocrinol Metab; 2020 Dec; 105(12):e4351-9. PubMed ID: 32893856
[TBL] [Abstract][Full Text] [Related]
20. MODY in Iceland is associated with mutations in HNF-1alpha and a novel mutation in NeuroD1.
Kristinsson SY; Thorolfsdottir ET; Talseth B; Steingrimsson E; Thorsson AV; Helgason T; Hreidarsson AB; Arngrimsson R
Diabetologia; 2001 Nov; 44(11):2098-103. PubMed ID: 11719843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
